Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kaye

Showing results (661-670 of 853) with videos related to

Pageof 86
Sort By:
European Journal of Cancer & Clinical Oncology|September 1, 1987
The effect of the non-ionic surfactant Brij 30 on the cytotoxicity of adriamycin in monolayer, spheroid and clonogenic culture systemsD J Kerr, T E Wheldon, J G Russell, et al.
Cancer Research|June 1, 1986
Phase I and pharmacokinetic study of LM985 (flavone acetic acid ester)D J Kerr, S B Kaye, J Graham, et al.
Translational Vision Science & Technology|May 15, 2023
Deep Learning Using Preoperative AS-OCT Predicts Graft Detachment in DMEKAlastair Patefield, Yanda Meng, Matteo Airaldi, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1986
TNO-6 has no effect in gastrointestinal cancer: N-acetyl-glucosaminidase shows renal damageD Cunningham, M Soukop, N L Gilchrist, et al.
British Medical Journal (Clinical Research Ed.)|February 23, 1985
Randomised trial of intravenous high dose metoclopramide and intramuscular chlorpromazine in controlling nausea and vomiting induced by cytotoxic drugsD Cunningham, M Soukop, N L Gilchrist, et al.
Investigational New Drugs|January 1, 1990
Phase II trials with flavone acetic acid (NCS. 347512, LM975) in patients with advanced carcinoma of the breast, colon, head and neck and melanomaS B Kaye, M Clavel, P Dodion, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1991
Epirubicin at two dose levels with prednisolone as treatment for advanced breast cancer: the results of a randomized trialT Habeshaw, J Paul, R Jones, et al.
Cancer Chemotherapy and Pharmacology|November 12, 2010
Clinical benefit of early phase clinical trial participation for advanced sarcoma patientsRobin L Jones, David Olmos, Khin Thway, et al.
European Journal of Ophthalmology|May 5, 2021
Rebubbling rate in preloaded versus surgeon prepared DSAEKLuca Pagano, Kunal A Gadhvi, Giulia Coco, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Docetaxel (Taxotere) in advanced renal cell cancer. A phase II trial of the EORTC Early Clinical Trials GroupU Bruntsch, B Heinrich, S B Kaye, et al.
Pageof 86

Showing results (661-670 of 853) with videos related to

Sort By:
Pageof 86
European Journal of Cancer & Clinical Oncology|September 1, 1987
The effect of the non-ionic surfactant Brij 30 on the cytotoxicity of adriamycin in monolayer, spheroid and clonogenic culture systemsD J Kerr, T E Wheldon, J G Russell, et al.
Cancer Research|June 1, 1986
Phase I and pharmacokinetic study of LM985 (flavone acetic acid ester)D J Kerr, S B Kaye, J Graham, et al.
Translational Vision Science & Technology|May 15, 2023
Deep Learning Using Preoperative AS-OCT Predicts Graft Detachment in DMEKAlastair Patefield, Yanda Meng, Matteo Airaldi, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1986
TNO-6 has no effect in gastrointestinal cancer: N-acetyl-glucosaminidase shows renal damageD Cunningham, M Soukop, N L Gilchrist, et al.
British Medical Journal (Clinical Research Ed.)|February 23, 1985
Randomised trial of intravenous high dose metoclopramide and intramuscular chlorpromazine in controlling nausea and vomiting induced by cytotoxic drugsD Cunningham, M Soukop, N L Gilchrist, et al.
Investigational New Drugs|January 1, 1990
Phase II trials with flavone acetic acid (NCS. 347512, LM975) in patients with advanced carcinoma of the breast, colon, head and neck and melanomaS B Kaye, M Clavel, P Dodion, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1991
Epirubicin at two dose levels with prednisolone as treatment for advanced breast cancer: the results of a randomized trialT Habeshaw, J Paul, R Jones, et al.
Cancer Chemotherapy and Pharmacology|November 12, 2010
Clinical benefit of early phase clinical trial participation for advanced sarcoma patientsRobin L Jones, David Olmos, Khin Thway, et al.
European Journal of Ophthalmology|May 5, 2021
Rebubbling rate in preloaded versus surgeon prepared DSAEKLuca Pagano, Kunal A Gadhvi, Giulia Coco, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Docetaxel (Taxotere) in advanced renal cell cancer. A phase II trial of the EORTC Early Clinical Trials GroupU Bruntsch, B Heinrich, S B Kaye, et al.
Pageof 86